These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23523162)

  • 1. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.
    Perlee LT; Bansal AT; Gehrs K; Heier JS; Csaky K; Allikmets R; Oeth P; Paladino T; Farkas DH; Rawlings PL; Hageman GS
    Ophthalmology; 2013 Sep; 120(9):1880-92. PubMed ID: 23523162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration.
    Saade C; Ganti B; Marmor M; Freund KB; Smith RT
    Br J Ophthalmol; 2014 Dec; 98(12):1729-32. PubMed ID: 25091949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors.
    Chen Y; Zeng J; Zhao C; Wang K; Trood E; Buehler J; Weed M; Kasuga D; Bernstein PS; Hughes G; Fu V; Chin J; Lee C; Crocker M; Bedell M; Salasar F; Yang Z; Goldbaum M; Ferreyra H; Freeman WR; Kozak I; Zhang K
    Arch Ophthalmol; 2011 Mar; 129(3):344-51. PubMed ID: 21402993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
    Hageman GS; Gehrs K; Lejnine S; Bansal AT; Deangelis MM; Guymer RH; Baird PN; Allikmets R; Deciu C; Oeth P; Perlee LT
    Hum Genomics; 2011 Jul; 5(5):420-40. PubMed ID: 21807600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals.
    Seddon JM; Rosner B
    Am J Ophthalmol; 2019 Feb; 198():223-261. PubMed ID: 30389371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models of choroidal neovascularization and geographic atrophy incidence applied to clinical trial design.
    McCarthy LC; Newcombe PJ; Whittaker JC; Wurzelmann JI; Fries MA; Burnham NR; Cai G; Stinnett SW; Trivedi TM; Xu CF
    Am J Ophthalmol; 2012 Sep; 154(3):568-578.e12. PubMed ID: 22704140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration.
    Sobrin L; Reynolds R; Yu Y; Fagerness J; Leveziel N; Bernstein PS; Souied EH; Daly MJ; Seddon JM
    Am J Ophthalmol; 2011 Feb; 151(2):345-52.e3. PubMed ID: 21122828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization.
    Grob S; Luo J; Hughes G; Lee C; Zhou X; Lee J; Du H; Ferreyra H; Freeman WR; Kozak I; Zhang K
    Eye (Lond); 2012 Aug; 26(8):1106-13. PubMed ID: 22699975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of geographic atrophy and genotype in age-related macular degeneration.
    Klein ML; Ferris FL; Francis PJ; Lindblad AS; Chew EY; Hamon SC; Ott J
    Ophthalmology; 2010 Aug; 117(8):1554-9, 1559.e1. PubMed ID: 20381870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
    Sobrin L; Ripke S; Yu Y; Fagerness J; Bhangale TR; Tan PL; Souied EH; Buitendijk GH; Merriam JE; Richardson AJ; Raychaudhuri S; Reynolds R; Chin KA; Lee AY; Leveziel N; Zack DJ; Campochiaro P; Smith RT; Barile GR; Hogg RE; Chakravarthy U; Behrens TW; Uitterlinden AG; van Duijn CM; Vingerling JR; Brantley MA; Baird PN; Klaver CC; Allikmets R; Katsanis N; Graham RR; Ioannidis JP; Daly MJ; Seddon JM
    Ophthalmology; 2012 Sep; 119(9):1874-85. PubMed ID: 22705344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.
    Schwartz SG; Agarwal A; Kovach JL; Gallins PJ; Cade W; Postel EA; Wang G; Ayala-Haedo J; Spencer KM; Haines JL; Pericak-Vance MA; Scott WK
    Retina; 2012 Sep; 32(8):1486-91. PubMed ID: 22481475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster Analysis and Genotype-Phenotype Assessment of Geographic Atrophy in Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 25.
    Keenan TDL; Oden NL; Agrón E; Clemons TE; Henning A; Fritsche LG; Wong WT; Chew EY;
    Ophthalmol Retina; 2021 Nov; 5(11):1061-1073. PubMed ID: 34325054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype- and Phenotype-Based Subgroups in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The EYE-RISK Consortium.
    Biarnés M; Colijn JM; Sousa J; Ferraro LL; Garcia M; Verzijden T; Meester-Smoor MA; Delcourt C; Klaver CCW; den Hollander AI; Lengyel I; Peto T; Monés J;
    Ophthalmol Retina; 2020 Dec; 4(12):1129-1137. PubMed ID: 32371126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.
    Maguire MG; Daniel E; Shah AR; Grunwald JE; Hagstrom SA; Avery RL; Huang J; Martin RW; Roth DB; Castellarin AA; Bakri SJ; Fine SL; Martin DF;
    Ophthalmology; 2013 Oct; 120(10):2035-41. PubMed ID: 23706946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
    Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
    Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.
    Thee EF; Colijn JM; Cougnard-Grégoire A; Meester-Smoor MA; Verzijden T; Hoyng CB; Fauser S; Hense HW; Silva R; Creuzot-Garcher C; Ueffing M; Delcourt C; den Hollander AI; Klaver CCW;
    Ophthalmology; 2022 Jul; 129(7):752-764. PubMed ID: 35240203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and progression of geographic atrophy: observations from a population-based cohort.
    Joachim N; Mitchell P; Kifley A; Rochtchina E; Hong T; Wang JJ
    Ophthalmology; 2013 Oct; 120(10):2042-50. PubMed ID: 23706948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.